Showing codes Q4310 (Procenta, per 100 mg) — Q5119 (Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg)

Q4310 - Procenta, per 100 mg
Long description: Procenta, per 100 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5 - Recip bill arr subs md or pt
Long description: Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
Code added date: 19930101.
Code effective date: 20170701.
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5001 - Hospice or home hlth in home
Long description: Hospice or home health care provided in patient's home/residence
Code added date: 20070101.
Code effective date: 20130701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5002 - Hospice/home hlth in asst lv
Long description: Hospice or home health care provided in assisted living facility
Code added date: 20070101.
Code effective date: 20130701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5003 - Hospice in lt/non-skilled nf
Long description: Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5004 - Hospice in snf
Long description: Hospice care provided in skilled nursing facility (snf)
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5005 - Hospice, inpatient hospital
Long description: Hospice care provided in inpatient hospital
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5006 - Hospice in hospice facility
Long description: Hospice care provided in inpatient hospice facility
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5007 - Hospice in ltch
Long description: Hospice care provided in long term care facility
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5008 - Hospice in inpatient psych
Long description: Hospice care provided in inpatient psychiatric facility
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5009 - Hospice/home hlth, place nos
Long description: Hospice or home health care provided in place not otherwise specified (nos)
Code added date: 20070101.
Code effective date: 20130701.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5010 - Hospice home care in hospice
Long description: Hospice home care provided in a hospice facility
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5101 - Injection, zarxio
Long description: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
Code added date: 20150701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5102 - Inj., infliximab biosimilar
Long description: Injection, infliximab, biosimilar, 10 mg
Code added date: 20160701.
Code effective date: 20180401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5103 - Injection, inflectra
Long description: Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
Code added date: 20180401.
Code effective date: 20180401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5104 - Injection, renflexis
Long description: Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
Code added date: 20180401.
Code effective date: 20180401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5105 - Inj retacrit esrd on dialysi
Long description: Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
Code added date: 20180701.
Code effective date: 20200101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5106 - Inj retacrit non-esrd use
Long description: Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
Code added date: 20180701.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5107 - Inj mvasi 10 mg
Long description: Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5108 - Injection, fulphila
Long description: Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
Code added date: 20181001.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5109 - Injection, ixifi, 10 mg
Long description: Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5110 - Nivestym
Long description: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Code added date: 20181001.
Code effective date: 20181001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5111 - Injection, udenyca 0.5 mg
Long description: Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
Code added date: 20190101.
Code effective date: 20230401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5112 - Inj ontruzant 10 mg
Long description: Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
Code added date: 20190701.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5113 - Inj herzuma 10 mg
Long description: Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
Code added date: 20190701.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5114 - Inj ogivri 10 mg
Long description: Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5115 - Inj truxima 10 mg
Long description: Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q5116 - Inj., trazimera, 10 mg
Long description: Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5117 - Inj., kanjinti, 10 mg
Long description: Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5118 - Inj., zirabev, 10 mg
Long description: Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q5119 - Inj ruxience, 10 mg
Long description: Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF